Lack of association between the hSKCa3 channel gene CAG polymorphism and schizophrenia

被引:0
|
作者
Joober, R
Benkelfat, C
Brisebois, K
Lafrenière, RGA
Turecki, G
Lal, S
Bloom, D
Labelle, A
Lalonde, P
Fortin, D
Alda, M
Morgan, K
Palmour, R
Rouleau, GA
机构
[1] McGill Univ, Montreal, PQ H3A 2T5, Canada
[2] Douglas Hosp, Montreal, PQ, Canada
[3] Montreal Gen Hosp, Inst Res, Montreal, PQ, Canada
来源
AMERICAN JOURNAL OF MEDICAL GENETICS | 1998年 / 81卷 / 06期
关键词
D O I
暂无
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
引用
收藏
页码:508 / 508
页数:1
相关论文
共 50 条
  • [21] Association between hSKCa3 and schizophrenia not confirmed by transmission disequilibrium test in 193 offspring parents trios
    Wittekindt, O
    Schwab, SG
    Burgert, E
    Knapp, M
    Albus, M
    Lerer, B
    Hallmayer, J
    Rietschel, M
    Segman, R
    Borrman, M
    Lichtermann, D
    Crocq, MA
    Maier, W
    Morris-Rosendahl, DJ
    Wildenauer, DB
    MOLECULAR PSYCHIATRY, 1999, 4 (03) : 267 - 270
  • [22] Association between anorexia nervosa and the hsKCa3 gene: A family-based and case control study
    Koronyo-Hamaoui M.
    Danziger Y.
    Frisch A.
    Stein D.
    Leor S.
    Laufer N.
    Carel C.
    Fennig S.
    Minoumi M.
    Apter A.
    Goldman B.
    Barkai G.
    Weizman A.
    Gak E.
    Molecular Psychiatry, 2002, 7 (1) : 82 - 85
  • [23] Association between anorexia nervosa and the hsKCa3 gene: a family-based and case control study
    Koronyo-Hamaoui, M
    Danziger, Y
    Frisch, A
    Stein, D
    Leor, S
    Laufer, N
    Carel, C
    Fennig, S
    Minoumi, M
    Apter, A
    Goldman, B
    Barkai, G
    Weizman, A
    Gak, E
    MOLECULAR PSYCHIATRY, 2002, 7 (01) : 82 - 85
  • [24] The human small conductance calcium-regulated potassium channel gene (hSKCa3) contains two CAG repeats in exon 1, is on chromosome 1q21.3, and shows a possible association with schizophrenia
    Oliver Wittekindt
    Anna Jauch
    Edgar Burgert
    Lars Schärer
    Heidi Holtgreve-Grez
    Gael Yvert
    Georges Imbert
    Jürgen Zimmer
    Margret R. Hoehe
    Jean-Paul Macher
    Pierre Chiaroni
    Dietrich van Calker
    Marc-Antoine Crocq
    D. J. Morris-Rosendahl
    Neurogenetics, 1998, 1 : 259 - 265
  • [25] CAG repeat polymorphisms in HSKCa3 and SCA12 show no association or linkage to schizophrenia but have shorter mean allele sizes in a Xhosa population
    Laurent, C
    Niehaus, D
    Soubigou, S
    Levinson, DF
    Emsley, R
    Deleuze, JF
    Mallet, J
    AMERICAN JOURNAL OF MEDICAL GENETICS, 2001, 105 (07): : 624 - 624
  • [26] HSKCa3 as a candidate gene in schizophrenic and bipolar disorders
    Rohrmeier, T
    Schöler, A
    Putzhammer, A
    Sartor, H
    Nöthen, MM
    Albus, M
    Klein, HE
    Eichhammer, P
    PSYCHIATRISCHE PRAXIS, 2000, 27 : S6 - S7
  • [27] The human small conductance calcium-regulated potassium channel gene (hSKCa3) contains two CAG repeats in exon 1, is on chromosome 1q21.3, and shows a possible association with schizophrenia
    Wittekindt, O
    Jauch, A
    Burgert, E
    Scharer, L
    Holtgreve-Grez, H
    Yvert, G
    Imbert, G
    Zimmer, J
    Hoehe, MR
    Macher, JP
    Chiaroni, P
    van Calker, D
    Crocq, MA
    Morris-Rosendahl, DJ
    NEUROGENETICS, 1998, 1 (04) : 259 - 265
  • [28] Association between a CAG repeat polymorphism in the hKCa3 channel gene and spinocerebellar ataxia (SCA).
    Figueroa, K
    Geshwind, D
    Perlman, S
    Chan, P
    Tanner, C
    Pulst, S
    AMERICAN JOURNAL OF HUMAN GENETICS, 1999, 65 (04) : A249 - A249
  • [29] Lack of association between schizophrenia and a polymorphism close to the cytosolic phospholipase A(2) gene
    Price, SA
    Fox, H
    StClair, D
    Shaw, DJ
    PSYCHIATRIC GENETICS, 1997, 7 (03) : 111 - 114
  • [30] Lack of association between CAG repeat polymorphism in the androgen receptor gene and the outcome of rheumatoid arthritis treatment with leflunomide
    Violetta Dziedziejko
    Mateusz Kurzawski
    Krzysztof Safranow
    Andrzej Ossowski
    Jaroslaw Piatek
    Miroslaw Parafiniuk
    Dariusz Chlubek
    Andrzej Pawlik
    European Journal of Clinical Pharmacology, 2012, 68 : 371 - 377